C-cell hyperplasia and medullary thyroid microcarcinoma

Area of Science:

• Endocrinology
• Oncology
• Pathology

Background:

• The thyroid C-cell's origin, function, and pathology have been extensively studied.
• Understanding C-cell hyperplasia and medullary microcarcinoma is crucial for thyroid cancer diagnosis and management.

Purpose of the Study:

• To summarize and update knowledge on physiologic C-cell hyperplasia, neoplastic C-cell hyperplasia (medullary carcinoma in situ), and medullary microcarcinoma.
• To discuss diagnostic challenges and advancements in differentiating C-cell related thyroid conditions.

Main Methods:

• Review of existing literature on C-cell hyperplasia and medullary microcarcinoma.
• Discussion of diagnostic criteria, including immunohistochemistry, quantitative analysis, and genetic testing (RET protooncogene mutations).

Main Results:

• Physiologic C-cell hyperplasia is associated with various thyroid disorders and hypercalcemia, with unclear pathogenesis and unknown malignant potential.
• Familial C-cell hyperplasia, linked to MEN II syndromes or familial medullary carcinoma, shows neoplastic characteristics and can be diagnosed preoperatively via genetic testing.
• Medullary microcarcinoma (<1 cm) has distinct features and behavior compared to larger tumors; familial forms are identified by genetic testing, and its frequency is expected to rise.

Conclusions:

• Accurate diagnosis of C-cell hyperplasia and medullary microcarcinoma relies on a combination of morphologic, immunohistochemical, and genetic analyses.
• Genetic testing, particularly for RET protooncogene mutations, is vital for early diagnosis and management of familial C-cell neoplasms.
• Further research is needed to clarify the pathogenesis and malignant potential of physiologic C-cell hyperplasia.